HomeCompaniesProfile

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing 


Company Size

1 - 5 employees

Year Founded

2015


About Indee Labs

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Founders & Key People

Ryan Pawell

Ryan Pawell

Founder/CEO, Indee Labs

Share This Profile

More Companies

Enzyme

Automating regulatory approval & compliance for life science companies

Replo

Online commerce for the AI age

ScholarSite

AI-powered sales tax, VAT and GST compliance

Scispot

The Best Data Infrastructure for Biotechs

AlphaFlow

AlphaFlow is a technology-driven investment manager.

Satsuma

Reliable blockchain indexing & querying for web3 engineering teams.

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.